Navigation Links
Coherent, Inc. Announces Termination of SEC Informal Inquiry
Date:7/10/2008

SANTA CLARA, Calif., July 10 /PRNewswire-FirstCall/ -- Coherent, Inc. (Nasdaq: COHR), today announced that the Securities and Exchange Commission has formally notified the Company that its investigation of Coherent's historical stock option granting practices has been terminated and that it will not recommend any enforcement action.

Founded in 1966, Coherent, Inc. is a world leader in providing photonics based solutions to the commercial and scientific research markets and part of the Russell 2000. Please direct any questions to Leen Simonet, Chief Financial Officer at 408-764-4161. For more information about Coherent, visit the Company's Web site at http://www.coherent.com/ for product and financial updates.


'/>"/>
SOURCE Coherent, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Coherent, Inc. to Webcast Fourth Fiscal Quarter 2007 Results
2. Coherent, Inc. Receives Expected Letter from NASDAQ
3. Spectral announces exclusive distribution agreement in Russia for its EAA(TM) Sepsis Diagnostic Assay
4. Pinnacle Biologics Announces Agreement With pharmexx to Expand Sales Support Activities in Key European Markets
5. Vasogen Announces Second Quarter 2008 Results
6. Ovalum Ltd. Announces Sales Launch of CiTop™ Product-Line in Europe
7. ULURU Inc. Announces Update on Recent Development
8. Sigma-Aldrich Announces Collaboration With Metahelix Life Sciences
9. Royalty Pharma Announces that James Reddoch, Ph.D., Joins Management Team
10. Beckman Coulter Announces Second Quarter 2008 Earnings to be Released on Friday, July 25, 2008, Before Market Opens
11. Telik Announces Publication of Diabetes Research in Bioorganic & Medicinal Chemistry Letters
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/27/2016)... ... April 27, 2016 , ... ... its Scientific Advisory Board. Dr. Lamka will assist PathSensors in expanding the use ... , PathSensors deploys the CANARY® test platform for the detection of harmful pathogens, ...
(Date:4/27/2016)... MedDay, a biotechnology company focused on ... of Catherine Moukheibir as Chairman of its Board of Directors. ... Jacques Garaud , who contributed to the rapid development of ... Catherine started her career in strategy consulting and investment ... London .  She held C-Suite level roles in some ...
(Date:4/26/2016)... ... ... The European Patent Office (EPO) today announced that U.S. Biophysicist ... Inventor Award 2016 in the category "Non-European countries." The winners of the 11th edition ... on June 9th. , The human capacity to walk with fluidity is the sum ...
(Date:4/26/2016)... , ... April 26, 2016 , ... BioFactura, Inc ... Series A round of financing. Healthy investor interest drove significant oversubscription of the ... generic biologics, known as biosimilars, to the advanced preclinical stages. , Chief Executive Officer ...
Breaking Biology Technology:
(Date:3/10/2016)... , March 10, 2016 ... new market research report "Identity and Access Management Market ... Audit, Compliance, and Governance), by Organization Size, by Deployment, ... 2020", published by MarketsandMarkets, The market is estimated to ... 12.78 Billion by 2020, at a Compound Annual Growth ...
(Date:3/8/2016)... , March 8, 2016   Valencell , ... today announced it has secured $11M in Series ... Tech, a new venture fund being launched by ... participation from existing investors TDF Ventures and WSJ ... to continue its triple-digit growth and accelerate its ...
(Date:3/2/2016)... March 2, 2016 ... the "Global Biometrics as a Service ... --> http://www.researchandmarkets.com/research/cmt3hk/global_biometrics ) has ... Biometrics as a Service Market 2016-2020" ... Research and Markets ( http://www.researchandmarkets.com/research/cmt3hk/global_biometrics ) ...
Breaking Biology News(10 mins):